Phase 4 Head and Neck Clinical Trials

5 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–5 of 5 trials

Recruiting

Phase 4

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hepatocellular CarcinomaMetastatic Lung Non-Small Cell Carcinoma+18 more

OHSU Knight Cancer Institute160 enrolled1 locationNCT07405086

Recruiting

Phase 4

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

Head and Neck Squamous Cell Carcinoma

M.D. Anderson Cancer Center25 enrolled1 locationNCT06162377

Recruiting

Phase 4

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Breast NeoplasmsColorectal NeoplasmsHead and Neck Neoplasms+1 more

Rutgers, The State University of New Jersey100 enrolled12 locationsNCT07158164

Recruiting

Phase 4

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Head and Neck CancerVenous Thromboembolism

Kiranya Arnold76 enrolled1 locationNCT07189897

Recruiting

Phase 4

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Head and Neck CancerTrismusRadiation Therapy Recipient+1 more

National Taiwan University Hospital120 enrolled1 locationNCT06734598